Koers Helius Medical Technologies, Inc.
Aandelen
HSDT
US42328V8019
Geavanceerde medische apparatuur & technologie
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
5,83 USD | +4,11% | -0,51% | -27,48% |
28/03 | Transcript : Helius Medical Technologies, Inc., Q4 2023 Earnings Call, Mar 28, 2024 | |
12/03 | Helius Medical Technologies, Inc. Start open-label onderzoek voor registratieprogramma beroerte | CI |
Omzet 2023 | 644K 597K | Omzet 2024 * | 2,04 mln. 1,89 mln. | Marktkapitalisatie | 5,17 mln. 4,79 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2023 | -8 mln. -7,42 mln. | Nettowinst (verlies) 2024 * | -12 mln. -11,12 mln. | EV/omzet 2023 | 8,84 x |
Nettoliquiditeiten 2023 * | - 0 | Nettoliquiditeiten 2024 * | - 0 | EV/omzet 2024 * | 2,53 x |
K/w-verhouding 2023 |
-0,55
x | K/w-verhouding 2024 * |
-0,63
x | Werknemers | 26 |
Dividendrendement 2023 * |
-
| Dividendrendement 2024 * |
-
| Vrij verhandelbaar | 98,94% |
Recentste transcriptie over Helius Medical Technologies, Inc.
1 dag | +4,11% | ||
1 week | -0,51% | ||
Lopende maand | +27,85% | ||
1 maand | +31,90% | ||
3 maanden | -24,87% | ||
6 maanden | -35,93% | ||
Lopend jaar | -27,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Director of Finance/CFO | 63 | 09-06-20 | |
Chief Tech/Sci/R&D Officer | 57 | 08-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Edward Straw
BRD | Director/Board Member | 85 | 18-11-14 |
Dane Andreeff
CEO | Chief Executive Officer | 58 | 04-08-17 |
Blane Walter
CHM | Chairman | 53 | 29-12-15 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
28-03-24 | 5,83 | +4,11% | 10 697 |
27-03-24 | 5,6 | +0,36% | 4 967 |
26-03-24 | 5,58 | -1,93% | 17 339 |
25-03-24 | 5,69 | -1,75% | 2 791 |
22-03-24 | 5,792 | -1,17% | 5 061 |
uitgestelde koers Nasdaq, 28 maart 2024 om 21:30 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-27,48% | 5,17 mln. | |
+9,50% | 222 mld. | |
+7,95% | 185 mld. | |
+18,30% | 141 mld. | |
+18,47% | 100 mld. | |
+7,83% | 68,36 mld. | |
+25,32% | 57,52 mld. | |
-3,69% | 46,84 mld. | |
+4,66% | 42,64 mld. | |
+15,12% | 29,09 mld. |